|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Fibromyalgia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Myofascial Pain Syndromes | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Disease | |||||
| Muscular Diseases | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Neuromuscular Diseases | |||||
| Pathologic Processes | |||||
| Rheumatic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Fluoxetine | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antidepressive Agents | |||||
| Antidepressive Agents, Second-Generation | |||||
| Central Nervous System Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Neurotransmitter Uptake Inhibitors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Serotonin Agents | |||||
| Serotonin Uptake Inhibitors | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| University of Cincinnati | |||||
| Arnold, Lesley, M., M.D. | |||||